MX9203034A - Pteridinas que evitan la resistencia primaria y secundaria en la quimioterapia y medicamentos que las contienen. - Google Patents

Pteridinas que evitan la resistencia primaria y secundaria en la quimioterapia y medicamentos que las contienen.

Info

Publication number: MX9203034A
Authority: MX; Mexico
Prior art keywords: pteridines; group; chemotherapy; substituted; carbon atom
Prior art date: 1988-10-01

Application number

MX9203034A

Other languages

English (en)

Inventor

Armin Dr Heckel

Jorg Dr Lebsanft

Uwe Dr Bamberger

Avner Dr Ramu

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-01

Filing date

1992-06-19

Publication date

1992-07-01

1992-06-19 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1992-07-01 Publication of MX9203034A publication Critical patent/MX9203034A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

MX9203034A 1988-10-01 1992-06-19 Pteridinas que evitan la resistencia primaria y secundaria en la quimioterapia y medicamentos que las contienen. MX9203034A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3833393A DE3833393A1 (de)	1988-10-01	1988-10-01	Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number	Publication Date
MX9203034A true MX9203034A (es)	1992-07-01

Family

ID=6364156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9203034A MX9203034A (es)	1988-10-01	1992-06-19	Pteridinas que evitan la resistencia primaria y secundaria en la quimioterapia y medicamentos que las contienen.

Country Status (19)

Country	Link
EP (1)	EP0362645B1 (es)
JP (1)	JPH02256676A (es)
KR (1)	KR910006289A (es)
AT (1)	ATE106728T1 (es)
AU (1)	AU620645B2 (es)
DD (1)	DD299062A5 (es)
DE (2)	DE3833393A1 (es)
DK (1)	DK480489A (es)
ES (1)	ES2056174T3 (es)
FI (1)	FI92699C (es)
HU (1)	HU205761B (es)
IL (1)	IL91814A (es)
MX (1)	MX9203034A (es)
NO (1)	NO175979C (es)
NZ (1)	NZ230833A (es)
PT (1)	PT91836B (es)
SU (1)	SU1720491A3 (es)
UA (1)	UA8028A1 (es)
ZA (1)	ZA897414B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69920757T2 (de) *	1998-12-28	2005-12-15	4 AZA Bioscience N.V.	Immunosuppressive wirkungen von pteridinderivaten
US7276506B2 (en)	1998-12-28	2007-10-02	4 Aza Bioscience Nv	Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) *	2002-01-23	2004-09-30	Faustus Forschungs Cie. Translational Cancer Research Gmbh	Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
PL1663244T3 (pl) *	2003-09-12	2008-01-31	4 Aza Ip Nv	Pochodne pterydyny do leczenia chorób związanych z TNF-alfa
AU2004283479A1 (en) *	2003-10-17	2005-05-06	4 Aza Bioscience Nv	Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (ru) *	2005-05-12	2012-04-10	Тиботек Фармасьютикалз Лтд.	Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US9259426B2 (en)	2006-07-20	2016-02-16	Gilead Sciences, Inc.	4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009079A2 (en)	2006-07-20	2008-01-24	Gilead Sciences, Inc.	Substituted pteridines useful for the treatment and prevention of viral infections
AU2016216673B2 (en)	2015-03-04	2017-02-02	Gilead Sciences, Inc.	Toll like receptor modulator compounds
KR20160003575A (ko)	2015-11-09	2016-01-11	정민시	발전기용 동력전달장치
AU2017318601B2 (en)	2016-09-02	2020-09-03	Gilead Sciences, Inc.	Toll like receptor modulator compounds
US10640499B2 (en)	2016-09-02	2020-05-05	Gilead Sciences, Inc.	Toll like receptor modulator compounds
TWI751516B (zh)	2019-04-17	2022-01-01	美商基利科學股份有限公司	類鐸受體調節劑之固體形式
TW202212339A (zh)	2019-04-17	2022-04-01	美商基利科學股份有限公司	類鐸受體調節劑之固體形式
TWI879779B (zh)	2019-06-28	2025-04-11	美商基利科學股份有限公司	類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3574206A (en) *	1965-04-15	1971-04-06	Boehringer Sohn Ingelheim	2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (es) *	1966-10-14
DE1617336C2 (de) *	1966-11-25	1982-07-01	C.H. Boehringer Sohn, 6507 Ingelheim	Arzneimittel gegen Angina pectoris
DE1795515A1 (de) *	1967-08-18	1972-03-30	Thomae Gmbh Dr K	Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) *	1967-12-15	1972-01-27	Thomae Gmbh Dr K	4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) *	1969-04-25	1971-01-07	Boehringer Sohn Ingelheim	Herzwirksame Zubereitungen
US4767761A (en) *	1987-11-04	1988-08-30	Dana-Farber Cancer Institute, Inc.	Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

1988
- 1988-10-01 DE DE3833393A patent/DE3833393A1/de not_active Withdrawn
1989
- 1989-09-23 AT AT89117610T patent/ATE106728T1/de not_active IP Right Cessation
- 1989-09-23 ES ES89117610T patent/ES2056174T3/es not_active Expired - Lifetime
- 1989-09-23 EP EP89117610A patent/EP0362645B1/de not_active Expired - Lifetime
- 1989-09-23 DE DE58907824T patent/DE58907824D1/de not_active Expired - Fee Related
- 1989-09-26 AU AU41749/89A patent/AU620645B2/en not_active Ceased
- 1989-09-28 IL IL9181489A patent/IL91814A/en not_active IP Right Cessation
- 1989-09-28 PT PT91836A patent/PT91836B/pt not_active IP Right Cessation
- 1989-09-29 NZ NZ230833A patent/NZ230833A/en unknown
- 1989-09-29 FI FI894615A patent/FI92699C/fi not_active IP Right Cessation
- 1989-09-29 DD DD89333128A patent/DD299062A5/de not_active IP Right Cessation
- 1989-09-29 UA UA4742036A patent/UA8028A1/uk unknown
- 1989-09-29 ZA ZA897414A patent/ZA897414B/xx unknown
- 1989-09-29 NO NO893879A patent/NO175979C/no unknown
- 1989-09-29 HU HU895131A patent/HU205761B/hu not_active IP Right Cessation
- 1989-09-29 DK DK480489A patent/DK480489A/da not_active Application Discontinuation
- 1989-09-29 KR KR1019890014002A patent/KR910006289A/ko not_active Ceased
- 1989-09-29 JP JP1255126A patent/JPH02256676A/ja active Pending
- 1989-09-29 SU SU894742036A patent/SU1720491A3/ru active
1992
- 1992-06-19 MX MX9203034A patent/MX9203034A/es unknown

Also Published As

Publication number	Publication date
FI92699C (fi)	1994-12-27
KR910006289A (ko)	1991-04-29
ES2056174T3 (es)	1994-10-01
ZA897414B (en)	1991-06-26
NO893879D0 (no)	1989-09-29
SU1720491A3 (ru)	1992-03-15
NZ230833A (en)	1991-05-28
JPH02256676A (ja)	1990-10-17
IL91814A0 (en)	1990-06-10
NO175979C (no)	1995-01-11
NO175979B (no)	1994-10-03
FI92699B (fi)	1994-09-15
AU4174989A (en)	1990-04-05
EP0362645B1 (de)	1994-06-08
DE58907824D1 (de)	1994-07-14
HU205761B (en)	1992-06-29
EP0362645A2 (de)	1990-04-11
ATE106728T1 (de)	1994-06-15
AU620645B2 (en)	1992-02-20
DK480489A (da)	1990-04-02
FI894615A7 (fi)	1990-04-02
DK480489D0 (da)	1989-09-29
FI894615A0 (fi)	1989-09-29
HUT52504A (en)	1990-07-28
DE3833393A1 (de)	1990-04-05
PT91836B (pt)	1995-07-18
NO893879L (no)	1990-04-02
DD299062A5 (de)	1992-03-26
PT91836A (pt)	1990-04-30
EP0362645A3 (de)	1992-03-25
IL91814A (en)	1994-02-27
UA8028A1 (uk)	1995-12-26

Similar Documents

Publication	Publication Date	Title
MX9203034A (es)	1992-07-01	Pteridinas que evitan la resistencia primaria y secundaria en la quimioterapia y medicamentos que las contienen.
DE3669503D1 (de)	1990-04-19	Oberflaechenaktive n-(omega, omega-1-dialkoxy)- und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,n-trisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.
ES8307743A1 (es)	1983-08-16	"un procedimiento para la preparacion de derivados de pirrolidina".
DE3660286D1 (en)	1988-07-14	Arylcyclobutylalkyl amines and their use as antidepressive medicines
ES390924A1 (es)	1974-04-01	Procedimiento para la preparacion de derivados del acido nicotinico.
GB1191971A (en)	1970-05-13	2-Amino-6,7-Distributed-4H-1,3-Benzothiazine-4-Ones as Bronchodilators
GB1185934A (en)	1970-03-25	Derivatives of 1,3(2H,4H)-Dioxoisoquinoline and preparation thereof
SE314986B (es)	1969-09-22
ES390064A1 (es)	1974-08-01	Procedimiento de preparacion de derivados de aminometil-4'-espiro (dibenzo (a-d) cicloheptadi-z(o tri) eno-5:2'-dioxo- lano (1',3')).
ATE35133T1 (de)	1988-07-15	N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
GB1096351A (en)	1967-12-29	Improvements in or relating to piperazine derivatives
GB1405767A (en)	1975-09-10	Method formulation and pharmaceutical composition for reducing plasma lipid levels
ES345993A1 (es)	1969-01-16	Procedimiento para la obtencion de nuevas pteridinas.
GB1156781A (en)	1969-07-02	New Heterocyclic Compounds
ATE1672T1 (de)	1982-11-15	In 4-stellung substituierte 1-(aminoalkylamino)5,8-dihydroxy-anthrachinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen dieser verbindungen.
ES385640A2 (es)	1973-04-01	Un procedimiento para la preparacion de oxinas y sus deri- vados.
ES345991A1 (es)	1969-01-16	Procedimiento para la obtencion de nuevas pteridinas.
GB1067817A (en)	1967-05-03	Substituted piperazines
HUT64940A (en)	1994-03-28	Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
GB880334A (en)	1961-10-18	New hydrazinium compounds, their production and pharmaceutical compositions containing them
GB1060558A (en)	1967-03-08	Benzimidazole derivatives
ES304710A1 (es)	1964-12-01	Procedimiento para la preparaciën de 1,3,5-triacinas
GB1157246A (en)	1969-07-02	Dibenzothiepin Derivatives and their preparation
ES485333A1 (es)	1980-07-01	Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
GB1045657A (en)	1966-10-12	Dialkylaminoalkyl estrone oxime derivatives